Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
American Eagle Outfitters
AEO
$2.79B
| $57.3M | ﹤0.01% |
2,174,643
-2,560,198
| -54% | -$50.6M |
|
1952
Invesco S&P Global Water Index ETF
CGW
$1.07B
| $57.3M | ﹤0.01% |
909,559
+38,819
| +4% | +$2.48M |
|
1953
GlobalFoundries
GFS
$29.1B
| $57.2M | ﹤0.01% |
1,638,900
-1,084,549
| -40% | -$38.6M |
|
|
FLG
1954
Flagstar Bank National Association
FLG
$5.92B
| $57.2M | ﹤0.01% |
4,541,489
+622,033
| +16% | +$7.44M |
|
|
RA
1955
Brookfield Real Assets Income Fund
RA
$707M
| $57.2M | ﹤0.01% |
4,411,299
+118,651
| +3% | +$1.56M |
|
1956
Carter's
CRI
$1.44B
| $57.1M | ﹤0.01% |
1,762,036
+239,469
| +16% | +$7.48M |
|
1957
B2Gold
BTG
$6.78B
| $57M | ﹤0.01% |
12,635,354
+3,602,147
| +40% | +$16.8M |
|
1958
Marathon Digital Holdings
MARA
$3.82B
| $56.9M | ﹤0.01% |
6,338,225
+459,973
| +8% | +$6.79M |
|
1959
Chunghwa Telecom
CHT
$32.9B
| $56.9M | ﹤0.01% |
1,363,517
-1,826
| -0.1% | -$77.2K |
|
1960
OSI Systems
OSIS
$3.82B
| $56.9M | ﹤0.01% |
222,904
-38,687
| -15% | -$10.1M |
|
1961
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $56.8M | ﹤0.01% |
46,901
-1,314
| -3% | -$1.62M |
|
1962
Enova International
ENVA
$6.43B
| $56.8M | ﹤0.01% |
361,418
+28,749
| +9% | +$3.74M |
|
1963
Noble Corp
NE
$7.08B
| $56.6M | ﹤0.01% |
2,003,537
-46,489
| -2% | -$1.37M |
|
1964
Genmab
GMAB
$19.5B
| $56.5M | ﹤0.01% |
1,834,439
+159,865
| +10% | +$4.98M |
|
1965
Bio-Rad Laboratories Class A
BIO
$9.44B
| $56.5M | ﹤0.01% |
186,387
+12,325
| +7% | +$3.85M |
|
1966
Ubiquiti
UI
$35B
| $56.5M | ﹤0.01% |
102,022
+7,338
| +8% | +$4.64M |
|
1967
Equinox Gold
EQX
$13.6B
| $56.4M | ﹤0.01% |
4,016,673
+1,872,542
| +87% | +$23.6M |
|
1968
Invesco Variable Rate Investment Grade ETF
VRIG
$1.85B
| $56.4M | ﹤0.01% |
2,246,537
+205,031
| +10% | +$5.15M |
|
1969
MSC Industrial Direct
MSM
$6.65B
| $56.4M | ﹤0.01% |
670,330
+9,100
| +1% | +$789K |
|
|
EMA
1970
Emera Inc
EMA
$15.7B
| $56.3M | ﹤0.01% |
1,143,852
-3,919
| -0.3% | -$189K |
|
1971
Westlake Corp
WLK
$10B
| $56.2M | ﹤0.01% |
759,623
-56,006
| -7% | -$3.99M |
|
1972
Saic
SAIC
$5.25B
| $56.2M | ﹤0.01% |
557,939
+29,256
| +6% | +$2.79M |
|
1973
Global X US Preferred ETF
PFFD
$2.16B
| $56.1M | ﹤0.01% |
2,968,352
-1,487,319
| -33% | -$28.4M |
|
1974
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $56.1M | ﹤0.01% |
6,918,424
-526,888
| -7% | -$4.28M |
|
1975
Kiniksa Pharmaceuticals
KNSA
$6.17B
| $56.1M | ﹤0.01% |
1,360,044
-2,879
| -0.2% | -$115K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.